Published in Cleve Clin J Med on July 01, 2010
Research on the premotor symptoms of Parkinson's disease: clinical and etiological implications. Environ Health Perspect (2013) 0.98
α-Synuclein overexpressing transgenic mice show internal organ pathology and autonomic deficits. Neurobiol Dis (2012) 0.88
Determinants of exercise capacity in dilated cardiomyopathy: a prospective, explorative cohort study. Wien Klin Wochenschr (2012) 0.75
Partial IGF-1 deficiency is sufficient to reduce heart contractibility, angiotensin II sensibility, and alter gene expression of structural and functional cardiac proteins. PLoS One (2017) 0.75
Amine oxidase and amine metabolism. Pharmacol Rev (1952) 4.95
Alpha-synuclein overexpression in PC12 and chromaffin cells impairs catecholamine release by interfering with a late step in exocytosis. J Neurosci (2006) 3.37
Sympathetic cardioneuropathy in dysautonomias. N Engl J Med (1997) 3.14
Interplay between cytosolic dopamine, calcium, and alpha-synuclein causes selective death of substantia nigra neurons. Neuron (2009) 3.11
Evidence that incidental Lewy body disease is pre-symptomatic Parkinson's disease. Acta Neuropathol (2008) 2.46
Nonmotor symptoms of Parkinson's disease revealed in an animal model with reduced monoamine storage capacity. J Neurosci (2009) 2.29
Reduced vesicular storage of dopamine causes progressive nigrostriatal neurodegeneration. J Neurosci (2007) 2.28
Axonal alpha-synuclein aggregates herald centripetal degeneration of cardiac sympathetic nerve in Parkinson's disease. Brain (2007) 2.10
Supine low-frequency power of heart rate variability reflects baroreflex function, not cardiac sympathetic innervation. Heart Rhythm (2007) 2.01
QT interval variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol (2008) 1.85
Aggregation of alpha-synuclein by DOPAL, the monoamine oxidase metabolite of dopamine. Acta Neuropathol (2007) 1.72
Profound cardiac sympathetic denervation occurs in Parkinson disease. Brain Pathol (2005) 1.51
ALDH1 mRNA: presence in human dopamine neurons and decreases in substantia nigra in Parkinson's disease and in the ventral tegmental area in schizophrenia. Neurobiol Dis (2003) 1.45
Heart rate spectral analysis, cardiac norepinephrine spillover, and muscle sympathetic nerve activity during human sympathetic nervous activation and failure. Circulation (1994) 1.43
Alpha-synuclein overexpression increases cytosolic catecholamine concentration. J Neurosci (2006) 1.30
Gene expression profiling of sporadic Parkinson's disease substantia nigra pars compacta reveals impairment of ubiquitin-proteasome subunits, SKP1A, aldehyde dehydrogenase, and chaperone HSC-70. Ann N Y Acad Sci (2005) 1.23
Proteome analysis of human substantia nigra in Parkinson's disease. Proteome Sci (2008) 1.06
Association between cardiac denervation and parkinsonism caused by alpha-synuclein gene triplication. Brain (2004) 1.05
Preserved cardiac sympathetic nerve accounts for normal cardiac uptake of MIBG in PARK2. Mov Disord (2005) 1.02
Different histopathology accounting for a decrease in myocardial MIBG uptake in PD and MSA. Neurology (2001) 0.96
Short-term heart rate variability and cardiac norepinephrine spillover in patients with depression and panic disorder. Am J Physiol Heart Circ Physiol (2009) 0.94
Sympathetic neurocirculatory failure in Parkinson disease: Evidence for an etiologic role of alpha-synuclein. Ann Intern Med (2001) 0.90
Cardiac sympathetic denervation in Parkinson's disease linked to SNCA duplication. Acta Neuropathol (2008) 0.88
Serotonin produces monoamine oxidase-dependent oxidative stress in human heart valves. Am J Physiol Heart Circ Physiol (2009) 0.84
Heart rate variability measurement correlates with cardiac norepinephrine spillover in congestive heart failure. Am J Cardiol (2001) 0.79